Sequences

Sample result

SIINFEKL, an exact peptide

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

2,028 publications in 1,357 families match these filters.

  1. US 11253579-B22022-02-22

    Compositions and methods for inducing immune tolerance

    The University of Chicago and Anokion SA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  2. JP 2022516088-A2022-02-24

    CONJUGATED VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTI-TUMOR IMMUNE REDIRECTORS

    VERIMMUNE LLC,Joshua Weiyuan WANG,Nattha INGAVAT,Ken MATSUI

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  3. JP 2022517226-A2022-03-07

    CD200AR LIGANDS FOR CANCER IMMUNOTHERAPY

    REGENTS OF THE UNIVERSITY OF MINNESOTA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  4. METHODS AND COMPOSITIONS FOR TREATMENT OF PANCREATIC CANCER

    MEMORIAL SLOAN KETTERING CANCER CENTER

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 62/868976.

  5. US 11266728-B22022-03-08

    Compositions and methods for enhancement of immune responses

    NATIONAL HEALTH RESEARCH INSTITUTES

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  6. IMPROVED VACCINE FORMULATIONS

    Equaly S.A

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  7. US 11278604-B22022-03-22

    Mesoporous silica compositions comprising inflammatory cytokines comprising inflammatory cytokines for modulating immune responses

    President and Fellows of Harvard College

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  8. US 11279748-B22022-03-22

    Recombinant animal-free food compositions and methods of making them

    CLARA FOODS CO.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   257 SIINFEKL 264
    

    8 of 8 identical, no gaps.

  9. US 11285203-B22022-03-29

    Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

    VERIMMUNE INC.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  10. US 11291717-B12022-04-05

    Covalently modified antigens for improved immune response and/or stability

    DEFENCE THERAPEUTICS INC.

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   257 SIINFEKL 264
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  11. JP 2022521972-A2022-04-13

    COMPOUNDS USEFUL AS ADJUVANTS

    MILLENNIUM PHARMACEUTICALS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  12. NON-ANIMAL BASED PROTEIN SOURCES WITH FUNCTIONAL PROPERTIES

    CLARA FOODS CO

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 309 to 316. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   309 SIINFEKL 316
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  13. A method for determining the specificity of a TCR-antigen using a single cell analysis

    Industry-Academic Cooperation Foundation, Yonsei University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  14. US 11320431-B22022-05-03

    Combination of reversible and irreversible cell labeling for analizing receptor-ligand koff rate

    TECHNISCHE UNIVERSITAET MUENCHEN and JUNO THERAPEUTICS GMBH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  15. US 11332537-B22022-05-17

    Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

    Celldex Therapeutics, Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  16. US 11338026-B22022-05-24

    Identification of immunologically protective neo-epitopes for the treatment of cancers

    THE UNIVERSITY OF CONNECTICUT and UNIVERSITY OF NOTRE DAME DUE LAC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  17. US 11338040-B22022-05-24

    Immunomodulatory compounds

    Leidos, Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  18. LIPID NANOPARTICLE LYOPHILIZED COMPOSITION

    NOF CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  19. US 11344611-B22022-05-31

    Polypeptide, compositions and uses thereof

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  20. US 11351271-B22022-06-07

    RNA-based logic circuits with RNA binding proteins, aptamers and small molecules

    Massachusetts Institute of Technology and Kyoto University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  21. JP 2022529154-A2022-06-17

    ANTI-MERTK ANTIBODIES AND METHODS OF USE

    Genentech Inc

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  22. Compositions comprising Fucoidan from Ecklonia cava as an active ingredient

    Industry Academic Cooperation Foundation of Yeungnam University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  23. US 11364292-B22022-06-21

    CHIKV RNA vaccines

    ModernaTX, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 27 to 34. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   27 SIINFEKL 34
    

    8 of 8 identical, no gaps.

  24. ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENS

    GRITSTONE BIO, INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 62/936303.

  25. US 11382886-B22022-07-12

    Methods and compositions for treating cancer

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  26. US 11382952-B22022-07-12

    Molecular marker for cancer stem cell

    Sapporo Medical University and Sumitomo Pharma Co., Ltd.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  27. JP 2022535045-A2022-08-04

    A CHEMOENZYMATIC METHOD FOR THE DETECTION OF CELL-CELL PROXIMITY INTERACTION AND ISOLATION OF TUMOR-SPECIFIC ANTIGEN REACTIVE T CELLS FOR IMMUNE THERAPY

    The Scripps Research Institute

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  28. NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

    REGENERON PHARMACEUTICALS, INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  29. COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

    BRISTOL-MYERS SQUIBB COMPANY

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 62/950570.

  30. US 11427644-B22022-08-30

    Dual antigen-induced bipartite functional complementation

    Julius-Maxmillians-Universitat Wurzburg

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  31. JP 2022537920-A2022-08-31

    Improved vaccine formulations

    Imnate

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  32. JP 2022538284-A2022-09-01

    HDAC6-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF

    THE GEORGE WASHINGTON UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  33. POLYNUCLEOTIDE AND MEDICINAL COMPOSITION

    National University Corporation Tokai National Higher Education and Research System

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 30 to 37. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   30 SIINFEKL 37
    

    8 of 8 identical, no gaps.

  34. JP 2022539417-A2022-09-08

    HIV ANTIGENS AND MHC COMPLEXES

    GRITSTONE BIO INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    9 SIINFEKL 16
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 62/869877.

  35. JP 2022542320-A2022-09-30

    PEPTIDE-LOADED CARRIER SYSTEMS AND USES THEREOF

    Academia Sinica

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  36. Vaccine composition based on attenuated reovirus and Use thereof

    ViroCure, Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

  37. JP 2022543038-A2022-10-07

    A method of eliciting an immune response by administering a population of polymersomes having an associated antigen together with a population of polymersomes having an associated adjuvant as well as compositions comprising the two populations of polymersomes

    ACM Biolabs Pte Ltd

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  38. SYSTEMS AND METHODS FOR HIGH YIELDING RECOMBINANT MICROORGANISMS AND USES THEREOF

    CLARA FOODS CO

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 346 to 353. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   346 SIINFEKL 353
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  39. JP 2022543423-A2022-10-12

    METHODS AND APPARATUSES FOR MANUFACTURING FOR REMOVING MATERIAL FROM A THERAPEUTIC COMPOSITION

    NUTCRACKER THERAPEUTICS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. JP 2022543650-A2022-10-13

    MANIPULATION AND USE OF ANTIGEN-SPECIFIC REGULATORY T CELLS

    The Board of Trustees of the Leland Stanford Junior University, Naresha Saligrama,Mark Davis,Jing Li

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 62/882810.

  41. US 11484599-B22022-11-01

    Polymer conjugate vaccines

    The University of Chicago

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  42. ANTIGEN-PRESENTING EXTRACELLULAR VESICLES, COMPOSITION CONTAINING SAME, AND METHODS FOR PRODUCTION THEREOF

    NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

  43. IMMUNOREGULATORY METHOD, NUCLEIC ACID COMPOSITION FOR IMMUNOREGULATION AND USE THEREOF

    NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  44. CANCER IMMUNOTHERAPY USING TRANSFUSIONS OF ALLOGENEIC, TUMOR-SPECIFIC CD4+ T CELLS

    THE JOHNS HOPKINS UNIVERSITY

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  45. US 11498956-B22022-11-15

    Fusion peptides with antigens linked to short fragments of invariant chain(CD74)

    GLAXOSMITHKLINE BIOLOGICALS SA and UNIVERSITY OF COPENHAGEN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  46. JP 2022174273-A2022-11-22

    BIOMATERIALS FOR MODULATING IMMUNE RESPONSES

    PRESIDENT AND FELLOWS OF HARVARD COLLEGE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  47. US 11504419-B22022-11-22

    Individualized vaccines for cancer

    BioNTech SE and TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gGmbH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  48. US 11504425-B22022-11-22

    Amphiphilic oligodeoxynucleotide conjugates as adjuvant enhancers

    Wayne State University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  49. JP 2022549257-A2022-11-24

    Production and functionalization of nanoparticles derived from T5 phage and therapeutic uses

    NATIONAL CENTRE FOR SCIENTIFIC RESEARCH (CNRS),PARIS-SACLAY UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 423 to 430. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   423 SIINFEKL 430
    

    8 of 8 identical, no gaps.

  50. US 11510973-B22022-11-29

    Alphavirus antigen vectors

    GRITSTONE BIO, INC.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.